Emily Luisa Hill Ptc Therapeutics, Inc. (PTCT) insider trading activity

Emily Luisa Hill is CHIEF FINANCIAL OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 38,925 shares of PTCT, which is worth approximately $1.44 Million. The most recent transaction as insider was on Mar 27, 2023, when has been sold 7,363 shares (Common Stock) at a price of $45.0 per share, resulting in proceeds of $331,335. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.9K

0% 3M change

0% 12M change

Total Value Held $1.44 Million

Emily Luisa Hill Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 27 2023	SELL Open market or private sale	$331,335 $45.0 p/Share	7,363 Reduced 15.91%	38,925 Common Stock
Jan 31 2023	SELL Open market or private sale	$26,237 $45.63 p/Share	575 Reduced 1.23%	46,288 Common Stock
Jan 24 2023	SELL Open market or private sale	$10,581 $47.45 p/Share	223 Reduced 0.47%	46,863 Common Stock
Jan 11 2023	SELL Open market or private sale	$18,542 $44.36 p/Share	418 Reduced 0.88%	47,086 Common Stock
Jan 10 2023	SELL Open market or private sale	$21,336 $42.93 p/Share	497 Reduced 1.04%	47,504 Common Stock
Jan 09 2023	SELL Open market or private sale	$31,578 $41.66 p/Share	758 Reduced 1.55%	48,001 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	19,500 Added 28.57%	48,759 Common Stock
Mar 31 2022	SELL Open market or private sale	$298,840 $37.78 p/Share	7,910 Reduced 21.28%	29,259 Common Stock
Feb 01 2022	SELL Open market or private sale	$22,120 $40.0 p/Share	553 Reduced 1.47%	37,169 Common Stock
Jan 25 2022	SELL Open market or private sale	$8,294 $39.31 p/Share	211 Reduced 0.56%	37,722 Common Stock
Jan 07 2022	SELL Open market or private sale	$30,816 $38.52 p/Share	800 Reduced 3.46%	22,333 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	15,600 Added 29.14%	37,933 Common Stock
Jan 04 2022	SELL Open market or private sale	$7,121 $41.16 p/Share	173 Reduced 0.74%	23,133 Common Stock
Feb 01 2021	SELL Open market or private sale	$30,815 $56.96 p/Share	541 Reduced 2.27%	23,306 Common Stock
Jan 25 2021	SELL Open market or private sale	$17,064 $62.05 p/Share	275 Reduced 1.14%	23,847 Common Stock
Jan 08 2021	SELL Open market or private sale	$1,815,802 $69.75 p/Share	26,033 Reduced 51.91%	24,122 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	$606,048 $23.28 p/Share	26,033 Added 43.8%	33,400 Common Stock
Jan 06 2021	BUY Grant, award, or other acquisition	-	10,800 Added 30.93%	24,122 Common Stock
Jan 05 2021	SELL Open market or private sale	$17,963 $62.37 p/Share	288 Reduced 2.12%	13,322 Common Stock

Also insider at

REPL

Replimune Group, Inc. Healthcare

Chief Financial Officer

ELH

Emily Luisa Hill

CHIEF FINANCIAL OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account